drugset / Trial / NCT01675609

Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

NCT01675609

Phase 2 Completed 57 enrolled Eye Therapies, LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects

Timeline

Start
2012-08
Primary completion
2012-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.025 % Other

Indications